Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EMA begins safety review of ifosfamide cancer medicines

europeanpharmaceuticalreviewMarch 17, 2020

Tag: EMA , cancer , PRAC , ifosfamide

PharmaSources Customer Service